Figure 4
Changes in platelet counts over treatment. A) Proportion of patients with baseline platelet count <50 × 109/L whose platelet counts were <20 × 109/L at any point during the treatment cycle or overall. B) Percentages of patients with platelet counts <20 × 109/L at any point during the treatment cycle. C) Median percent decrease from the platelet count at day 1 to the nadir of each treatment cycle for all patients.